Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Life Meds vs Omada Health

Good Life Meds
Graded #463

Lower grade

vs+1.8000000000000043
Omada Health
Graded #435

Higher grade

The verdict

Omada Health takes it — 55.6/100 to 53.8/100, but only just.

Omada Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Omada Health is a virtual care company offering behavior-change programs for weight health, diabetes and hypertension, distributed through employers and health plans. Good Life Meds is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightOmada Health +5
72
77
Labs & monitoringOmada Health +8
53
61
FulfillmentGood Life Meds +3
65
62
Contract termsEven
55
55
Good Life Meds · left barOmada Health · right bar

The numbers

MetricGood Life MedsOmada Health
WeighScore53.8/10055.6/100
GradeCC
Scorecard rank#463#435
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Good Life Meds

Graded #463 · C

Strengths

  • Both semaglutide and tirzepatide available

Where it loses points

  • Pricing not publicly disclosed
Omada Health

Graded #435 · C

Strengths

  • Added GLP-1 prescribing and medication management in late 2025
  • Clinicians trained in obesity care, available in all 50 states
  • Behavioral support wrapped before, during and after treatment
  • GLP-1 Flex Care adds a cash-pay medication pathway in 2026
  • Publicly traded, evidence-based virtual care platform

Where it loses points

  • Core program distributed via employers and health plans, limited cash-pay
  • GLP-1 prescribing is a recent addition still scaling
  • GLP-1 Flex Care only rolling out to employers later in 2026
  • No transparent published price for the core member program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard